Jialei Wang

2.3k total citations
81 papers, 1.0k citations indexed

About

Jialei Wang is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Jialei Wang has authored 81 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Oncology, 38 papers in Pulmonary and Respiratory Medicine and 21 papers in Molecular Biology. Recurrent topics in Jialei Wang's work include Lung Cancer Treatments and Mutations (29 papers), Lung Cancer Research Studies (16 papers) and Cancer Immunotherapy and Biomarkers (10 papers). Jialei Wang is often cited by papers focused on Lung Cancer Treatments and Mutations (29 papers), Lung Cancer Research Studies (16 papers) and Cancer Immunotherapy and Biomarkers (10 papers). Jialei Wang collaborates with scholars based in China, United States and France. Jialei Wang's co-authors include Hui Yu, Xun Ye, Hui Yu, Fang Liu, Meng Xia, Qinghua Xu, Jianhua Chang, Zedi Zhang, Xiao Hu and Kaidong Han and has published in prestigious journals such as Nucleic Acids Research, Journal of Clinical Oncology and Cancer.

In The Last Decade

Jialei Wang

77 papers receiving 991 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jialei Wang China 17 391 352 299 286 107 81 1.0k
Yunhe Gao China 20 462 1.2× 420 1.2× 340 1.1× 384 1.3× 281 2.6× 74 1.3k
Yijie Zheng China 20 326 0.8× 209 0.6× 132 0.4× 222 0.8× 173 1.6× 41 1.1k
Fei Teng China 24 1.3k 3.4× 472 1.3× 221 0.7× 1.1k 3.7× 226 2.1× 107 2.4k
Zhihong Fan China 12 312 0.8× 514 1.5× 246 0.8× 79 0.3× 98 0.9× 31 983
Kaushal Parikh United States 12 368 0.9× 483 1.4× 237 0.8× 93 0.3× 36 0.3× 50 820
Zequn Li China 18 397 1.0× 219 0.6× 94 0.3× 195 0.7× 76 0.7× 54 871
Jongmin Sim South Korea 15 239 0.6× 122 0.3× 66 0.2× 119 0.4× 75 0.7× 49 534
Pablo Ramírez Chile 17 263 0.7× 372 1.1× 95 0.3× 50 0.2× 97 0.9× 53 1.3k
Vincenzo Bianco Italy 16 117 0.3× 190 0.5× 150 0.5× 67 0.2× 70 0.7× 68 736
Yonghui Huang China 17 155 0.4× 172 0.5× 191 0.6× 157 0.5× 291 2.7× 87 1.0k

Countries citing papers authored by Jialei Wang

Since Specialization
Citations

This map shows the geographic impact of Jialei Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jialei Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jialei Wang more than expected).

Fields of papers citing papers by Jialei Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jialei Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jialei Wang. The network helps show where Jialei Wang may publish in the future.

Co-authorship network of co-authors of Jialei Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Jialei Wang. A scholar is included among the top collaborators of Jialei Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jialei Wang. Jialei Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhou, Juan, et al.. (2025). Regulating the rheological properties of cement paste with fly ash and limestone powder. Construction and Building Materials. 504. 144680–144680.
2.
Zhang, Xupeng, et al.. (2025). Hetero-metal MOF derivatives anchored on porous carbonized wood as photo-Fenton catalysts for ultrafast organic pollutant removal. Journal of Photochemistry and Photobiology A Chemistry. 470. 116616–116616.
3.
Chu, Tianqing, Xiaorong Dong, Huijuan Wang, et al.. (2024). Heterogeneity in advanced pulmonary sarcomatoid carcinoma and its efficacy to immune checkpoint inhibitors. European Journal of Cancer. 209. 114260–114260. 2 indexed citations
4.
Zhang, Xin, Wenyue Yang, Zhen Wang, et al.. (2024). Plasma extracellular vesicle long RNA profiling identifies a predictive signature for immunochemotherapy efficacy in lung squamous cell carcinoma. Frontiers in Immunology. 15. 1421604–1421604. 1 indexed citations
6.
Lin, Ying, Bo Yu, Hongyu Zhang, et al.. (2023). Promising efficacy of immune checkpoint inhibitor plus chemotherapy for thoracic SMARCA4-deficient undifferentiated tumor. Journal of Cancer Research and Clinical Oncology. 149(11). 8663–8671. 20 indexed citations
7.
Lai, Hongyan, Chang Liu, Xin Zhang, et al.. (2023). Plasma extracellular vesicle transcriptomics identifies CD160 for predicting immunochemotherapy efficacy in lung cancer. Cancer Science. 114(7). 2774–2786. 6 indexed citations
8.
Guo, Yu, Dongdong Di, Shirong Wang, et al.. (2022). Molecular characterization of a novel subgenotype of lumpy skin disease virus strain isolated in Inner Mongolia of China. BMC Veterinary Research. 18(1). 295–295. 8 indexed citations
9.
Zhao, Xinmin, Xianghua Wu, Hui Yu, et al.. (2022). Prognostic value of hematologic parameters in advanced non-small cell lung cancer patients receiving anti-PD-1 inhibitors. Frontiers in Immunology. 13. 1003581–1003581. 4 indexed citations
10.
Sun, Si, Chang Liu, Qiao Zhang, et al.. (2022). Efficacy and safety of immune checkpoint inhibitors in post-TKI NSCLC patients harboring EGFR mutations. Journal of Cancer Research and Clinical Oncology. 149(7). 2937–2949. 5 indexed citations
12.
Hu, Xingjiang, Hui Yu, Yunliang Zheng, et al.. (2020). Immune Checkpoint Inhibitors and Survival Outcomes in Brain Metastasis: A Time Series-Based Meta-Analysis. Frontiers in Oncology. 10. 564382–564382. 12 indexed citations
13.
Sun, Si, Zhihuang Hu, Shenglin Huang, et al.. (2019). REG4 is an indicator for KRAS mutant lung adenocarcinoma with TTF-1 low expression. Journal of Cancer Research and Clinical Oncology. 145(9). 2273–2283. 8 indexed citations
14.
Chu, Li, Jianjiao Ni, Xi Yang, et al.. (2019). Radiographic Features of Metastatic Brain Tumors from ALK-rearranged Non-small Cell Lung Cancer: Implications for Optimal Treatment Modalities. Journal of Cancer. 10(26). 6660–6665. 3 indexed citations
15.
Sun, Si, Hui Yu, Huijie Wang, et al.. (2019). Phase II Study of S-1 plus Cisplatin as First-Line Therapy in Patients with Metastatic Esophageal Carcinoma. Oncology Research and Treatment. 42(3). 115–122. 8 indexed citations
16.
Wang, Jialei, et al.. (2015). Determination of 33 kinds of metallic elements in food aquatic products and animal tissues by microwave digestion and ICP-MS method.. Shipin anquan zhiliang jiance xuebao. 6(3). 953–961. 1 indexed citations
17.
Yu, Hui, Qinghua Xu, Fang Liu, et al.. (2015). Identification and Validation of Long Noncoding RNA Biomarkers in Human Non–Small-Cell Lung Carcinomas. Journal of Thoracic Oncology. 10(4). 645–654. 114 indexed citations
19.
20.
Wang, Jialei, Jin Li, Xiaonan Hong, et al.. (2007). Retrospective case series of gemcitabine plus cisplatin in the treatment of recurrent and metastatic nasopharyngeal carcinoma. Oral Oncology. 44(5). 464–470. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026